MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

COLLEGIUM PHARMACEUTICAL, INC (COLL)

COLLEGIUM PHARMACEUTICAL, INC (COLL)

|||

Balance Sheets Overview

Current Ratio
103.08%
Quick Ratio
83.87%
Cash Ratio
21.95%
Debt to Asset Ratio
85.40%
Unit: Thousand (K) dollars
Assets Breakdown
    • Intangible assets, net
    • Total current assets
    • Goodwill
    • Others
Liabilities Breakdown
    • Term notes payable, net of curre...
    • Additional paid-in capital
    • Accrued rebates, returns and dis...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
129,467
268,648
231,252
150,096
Marketable securities
0
153,105
155,427
135,767
Accounts receivable, net
285,102
228,762
211,328
233,949
Inventory
113,269
42,741
40,912
38,052
Prepaid expenses and other current assets
60,326
32,562
32,642
36,156
Restricted cash
19,850
19,850
19,850
19,850
Total current assets
608,014
745,668
691,411
613,870
Property and equipment, net
10,653
11,661
12,013
12,249
Operating lease assets
3,791
3,975
4,187
4,432
Intangible assets, net
1,186,084
614,037
669,510
724,983
Restricted cash
1,060
1,058
1,056
1,054
Deferred tax assets
120,774
113,567
112,539
102,477
Other noncurrent assets
15,237
16,064
20,193
2,338
Goodwill
190,177
145,925
145,925
145,925
Total assets
2,135,790
1,651,955
1,656,834
1,607,328
Accounts payable
9,241
6,828
10,659
7,647
Accrued liabilities
71,250
58,148
62,464
51,468
Accrued rebates, returns and discounts
406,854
317,691
318,266
309,608
Current portion of term notes payable
55,000
32,625
29,000
64,583
Current portion of operating lease liabilities
1,561
1,449
1,407
1,372
Business combination consideration payable
29,719
-
-
17,565
Current portion of contingent consideration
15,569
17,565
17,565
19
Deferred revenue
667
667
667
667
Total current liabilities
589,861
434,973
440,028
452,929
Term notes payable, net of current portion
797,824
531,723
542,112
505,583
Convertible senior notes
238,733
238,472
238,213
237,950
Operating lease liabilities, net of current portion
3,407
3,787
4,132
4,501
Deferred royalty obligation
121,357
121,634
121,563
122,279
Deferred revenue, net of current portion
8,778
8,944
9,111
9,278
Contingent consideration, net of current portion
22,956
-
0
-
Deferred tax liabilities
40,965
-
-
-
Total liabilities
1,823,881
1,339,533
1,355,159
1,332,520
Common stock, 0.001 par value authorized shares - 100,000,000 40,629,601 issued and 31,600,879 outstanding shares as of march 31, 2026 and 39,646,749 issued and 31,440,155 outstanding shares as of december 31, 2024
41
41
41
41
Additional paid-in capital
636,062
621,743
624,954
615,077
Treasury stock, at cost 9,028,722 shares as of june30, 2026 and december31, 2025
222,510
222,510
222,510
222,510
Accumulated other comprehensive income
0
-219
319
292
Accumulated deficit
-101,684
-86,633
-101,129
-118,092
Total shareholders equity
311,909
312,422
301,675
274,808
Total liabilities and shareholders equity
2,135,790
1,651,955
1,656,834
1,607,328
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, net$285,102K (33.84%↑ Y/Y)Cash and cashequivalents$129,467K (10.33%↑ Y/Y)Inventory$113,269K (196.92%↑ Y/Y)Prepaid expenses andother current assets$60,326K (7.65%↑ Y/Y)Restricted cash$19,850K (0.00%↑ Y/Y)Intangible assets, net$1,186,084K (51.97%↑ Y/Y)Total current assets$608,014K (10.71%↑ Y/Y)Goodwill$190,177K (28.55%↑ Y/Y)Deferred tax assets$120,774K (31.32%↑ Y/Y)Other noncurrentassets$15,237K (296.28%↑ Y/Y)Property and equipment,net$10,653K (-17.44%↓ Y/Y)Operating lease assets$3,791K (-27.97%↓ Y/Y)Restricted cash$1,060K (0.95%↑ Y/Y)Total assets$2,135,790K (34.10%↑ Y/Y)Total liabilities andshareholders equity$2,135,790K (34.10%↑ Y/Y)Total liabilities$1,823,881K (34.07%↑ Y/Y)Total shareholdersequity$311,909K (34.32%↑ Y/Y)Treasury stock, at cost9,028,722 shares as of...$222,510K (2.30%↑ Y/Y)Accumulated deficit-$101,684K (32.03%↑ Y/Y)Term notes payable,net of current...$797,824K (53.24%↑ Y/Y)Total currentliabilities$589,861K (26.96%↑ Y/Y)Convertible senior notes$238,733K (0.44%↑ Y/Y)Deferred royaltyobligation$121,357K (-1.04%↓ Y/Y)Deferred tax liabilities$40,965K Contingent consideration,net of current...$22,956K Deferred revenue, net ofcurrent portion$8,778K (-12.22%↓ Y/Y)Operating leaseliabilities, net of current...$3,407K (-29.80%↓ Y/Y)Additional paid-in capital$636,062K (6.20%↑ Y/Y)Common stock, 0.001 parvalue authorized...$41K (2.50%↑ Y/Y)Accrued rebates,returns and discounts$406,854K (30.92%↑ Y/Y)Accrued liabilities$71,250K (19.88%↑ Y/Y)Current portion of termnotes payable$55,000K (-14.84%↓ Y/Y)Business combinationconsideration payable$29,719K (69.18%↑ Y/Y)Current portion ofcontingent consideration$15,569K (40871.05%↑ Y/Y)Accounts payable$9,241K (-15.14%↓ Y/Y)Current portion ofoperating lease...$1,561K (16.67%↑ Y/Y)Deferred revenue$667K (-93.33%↓ Y/Y)